4.10.29Segment

Women's Health & OB/GYN

OB/GYN group practices, fertility clinics, maternal-fetal medicine programs, and women's health platforms.

4
Verticals

Overview

Women's Health & OB/GYN covers OB/GYN group practices, fertility clinics, maternal-fetal medicine, and women's-health platforms. Most OB/GYN care sits within general physician offices, while fertility (IVF) has been a standout high-growth, cash-pay, and heavily consolidated sub-segment.

Demand is supported by women's-health awareness, delayed childbearing (fertility), and the consolidation of independent OB/GYN practices under MSO platforms (Unified Women's Healthcare, Axia, Ob Hospitalist Group). Fertility in particular has drawn intense private-equity interest.

Market snapshot

Market size
~$4.6B
Growth
~9.2%CAGR (2017–22, nominal)
Companies
~1,744 firms
Firms by employee count

83.8% of firms have fewer than 20 employees: 1,462 micro-businesses, below most mandates.

The investable universe282 firms with 20+ employees
20–99
17261%
100–499
8229%
500+
2810%

Only the family-planning-center slice (~1,700 firms, ~$4.6B) is separately coded — most OB/GYN care sits inside physician offices and isn't captured here, so this understates the true segment. What is measured grew fast (~9.2%/yr); women's health is an active PE roll-up theme (fertility, maternity, and comprehensive women's platforms) beyond this narrow code.

NAICS 621410. U.S. Census Bureau — 2022 Statistics of U.S. Businesses; U.S. Census Bureau — 2022 Economic Census.

Business model & economics

Revenue model

Reimbursed OB/GYN care plus cash-pay fertility

Key economics

Revenue per firm
$2,648,336
Revenue per employee
$160,444
Employees per firm
16.9
Recurring revenue
Moderate

recurring women's-health relationships

EBITDA margin
15–25%; fertility higher
Capex intensity
Moderate

Characteristics

  • Balanced cost base — payroll is 39% of revenue, leaving room to scale margin without cutting staff
  • Moderate strategic-buyer pool — 28 firms exceed 500 employees; a scaled asset has buyers, but not many
  • Fertility (IVF) the high-growth, cash-pay sub-segment.
  • MSO consolidation of OB/GYN practices.
  • Delayed childbearing and awareness drive demand.

NAICS 621410. U.S. Census Bureau — 2022 Statistics of U.S. Businesses; U.S. Census Bureau — 2022 Economic Census.

M&A deal context

Deal activityHigh

Who’s acquiring

  • Women's-health MSO platforms
  • Fertility-network consolidators
  • PE-backed acquirers

What’s driving deals

  • Fertility-network roll-up.
  • OB/GYN practice consolidation.
  • Cash-pay fertility demand.

Verticals in this segment

Find Women's Health & OB/GYN acquisition targets

Search Acquisera’s index for companies classified under Women's Health & OB/GYN (4.10.29) and build a targeted deal pipeline.

Search companies